Sec Form 13D Filing - Western Standard LLC filing for MERRIMACK PHARMACEUTICALS INC (MACK) - 2023-12-13

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 5)*

 

 

Merrimack Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock, $0.01 par value per share

(Title of Class of Securities)

590328209

(CUSIP Number)

Eric D. Andersen

Western Standard, LLC

5757 Wilshire Boulevard, Suite 636

Los Angeles, CA 90036

(310) 929-4301

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

December 7, 2023

(Date of Event which Requires Filing of this Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

 

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

 

 

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 590328209    13D    Page 2 of 9 Pages

 

  1.    

  NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Western Standard, LLC

  26-2921385

  2.  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

  (a)  ☒         (b)  ☐

 

  3.  

  SEC USE ONLY

 

  4.  

  SOURCE OF FUNDS (see instructions)

 

  AF

  5.  

  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6.  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  California

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

 

     7.    

  SOLE VOTING POWER

 

  2,220,058

     8.  

  SHARED VOTING POWER

 

  0

     9.  

  SOLE DISPOSITIVE POWER

 

  2,220,058

   10.  

  SHARED DISPOSITIVE POWER

 

  0

11.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  2,220,058

12.  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)

 

  ☐

13.  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  15.5%

14.  

  TYPE OF REPORTING PERSON (see instructions)

 

  IA

 


CUSIP No. 590328209    13D    Page 3 of 9 Pages

 

  1.    

  NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Eric D. Andersen

  2.  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

  (a)  ☒         (b)  ☐

 

  3.  

  SEC USE ONLY

 

  4.  

  SOURCE OF FUNDS (see instructions)

 

  AF

  5.  

  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6.  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States of America

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

 

     7.    

  SOLE VOTING POWER

 

  2,220,058

     8.  

  SHARED VOTING POWER

 

  0

     9.  

  SOLE DISPOSITIVE POWER

 

  2,220,058

   10.  

  SHARED DISPOSITIVE POWER

 

  0

11.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 &#x A0;2,220,058

12.  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)

 

  ☐

13.  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  15.5%

14.  

  TYPE OF REPORTING PERSON (see instructions)

 

  IN, HC

 


CUSIP No. 590328209    13D    Page 4 of 9 Pages

 

  1.    

  NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

  Western Standard Partners, L.P.

  26-2921468

  2.  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)

  (a)  ☒         (b)  ☐

 

  3.  

  SEC USE ONLY

 

  4.  

  SOURCE OF FUNDS (see instructions)

 

  WC

  5.  

  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

  ☐

  6.  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Delaware

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH

 

     7.    

  SOLE VOTING POWER

 

  1,735,600

     8.  

  SHARED VOTING POWER

 

  0

     9.  

  SOLE DISPOSITIVE POWER

 

  1,735,600

   10.  

  SHARED DISPOSITIVE POWER

 

  0

11.    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  1,735,600

12.  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)

 

  ☐

13.  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  12.1%

14.  

  TYPE OF REPORTING PERSON (see instructions)

 

  PN

 


This Amendment No. 5 is being jointly filed by (1) Western Standard, LLC (“Western Standard”), a California limited liability company, (2) Eric D. Andersen, a citizen of the United States of America, and (3) Western Standard Partners, L.P., a Delaware limited partnership (collectively, the “Reporting Persons”), to supplement and amend as specifically set forth herein the Schedule 13D originally filed on September 19, 2019 (the “Original Filing”), as amended by that certain Amendment No. 1 filed on September 27, 2019, that certain Amendment No. 2 filed on July 24, 2020, that certain Amendment No. 3 filed on December 3, 2020, and that certain Amendment No. 4 filed on August 14, 2023 (each, a “Prior Amendment” and collectively with the Original Filing and this Amendment No. 5, the “Schedule 13D”), with respect to the common stock, $0.01 par value per share (the “Common Stock”) of Merrimack Pharmaceuticals, Inc., a Delaware corporation (the “Issuer”). Except as specifically set forth herein, this Amendment No. 5 does not modify any of the information previously reported in the Schedule 13D. Capitalized terms used in this Amendment No. 5 and not otherwise defined herein shall have the respective meanings ascribed to them in the Prior Amendments.

Item 2. Identity and Background

Item 2 is hereby amended and restated to read as follows:

This Schedule 13D is being filed jointly and on behalf of the following persons:

(a) The term “Reporting Persons” collectively refers to:

 

   

Western Standard, LLC (“Western Standard”), a California limited liability company;

 

   

Eric D. Andersen, a citizen of the United States of America.

 

   

Western Standard Partners, L.P., a Delaware limited partnership.

(b) The business address of each Reporting Person is 5757 Wilshire Boulevard, Suite 636, Los Angeles, CA 90036.

(c) Western Standard is a registered investment adviser with the U.S. Securities and Exchange Commission (“SEC”) and its principal business is acting as the general partner and investment manager to Western Standard Partners, L.P. and Western Standard Partners QP, L.P. (each, a “Fund” and collectively with Mr. Andersen and Western Standard, the “Western Standard Parties”). The Funds directly own the reported shares.

The principal occupation of Mr. Andersen is acting as the Managing Member of Western Standard and portfolio manager to the Funds.

Western Standard Partners, L.P. is a private fund that is principally engaged in investing in a long/short equity strategy in “small cap” companies.

(d) During the last five years, none of the Reporting Persons have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

(e) During the last five years, none of the Reporting Persons have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f) The citizenship or place of organization for each of the Reporting Persons is set forth in Section 2(a) of this Schedule 13D and is incorporated herein by reference.

Item 3. Source and Amount of Funds or Other Consideration

Item 3 is hereby amended and restated to read as follows:

Since the last Prior Amendment, the Reporting Persons used working capital of the Funds to purchase the 228,950 shares of the Issuer’s Common Stock reported herein (the “Shares”) in open market transactions. The total purchase price for the Shares was approximately $2,883,982, including brokerage commissions.


The Reporting Persons effect purchases of securities in both private transactions and open market transactions. Open market transactions are made primarily through margin accounts maintained for the Reporting Persons with brokers, which may extend margin credit as and when required to open or carry positions in their margin accounts, subject to applicable federal margin regulations, stock exchange rules and such firms’ credit policies. Positions in the Issuer’s securities may be held in margin accounts and may be pledged as collateral security for the repayment of debit balances in such accounts. Such margin accounts may from time to time have debit balances. In addition, since other securities may be held in such margin accounts, it may not be possible to determine the amounts, if any, of margin used to purchase shares of the Common Stock. To the extent required by Item 3 of Schedule 13D, the information set forth in Item 6 of this Schedule 13D is incorporated herein by reference.

Item 5. Interest in Securities of the Issuer

Item 5 is hereby amended and restated to read as follows:

“Group” Status

As described in Item 4 of Amendment No. 1, as a result of the Western Standard Parties’ agreement with the Newtyn Parties (as defined below) to vote their respective shares of Common Stock to support the Issuer’s slate of director nominees and proposals in connection with the Annual Meeting and by entering into the Cooperation Agreement (a copy of which was previously filed as an attachment to the Original Filing), the Reporting Persons have formed a “group” for purposes of Section 13(d)(1) of the Exchange Act and the rules promulgated thereunder because of their agreement to vote jointly. The members of this group, in addition to the Western Standard Parties, are Noah G. Levy, Newtyn Management, LLC (“Newtyn Management”), Newtyn Capital Partners, LP (“NCP”), Ledo Capital, LLC (“Ledo”), and Newtyn Partners, LP and Newtyn TE Partners, LP (the “Newtyn Funds” and collectively with Mr. Levy, Newtyn Management, NCP and Ledo, the “Newtyn Parties”) (collectively, the “13D Group”).

Each of Mr. Levy, Newtyn Management, NCP, Ledo and Newtyn Partners, LP (collectively, the “Newtyn Reporting Persons”) as of the date of this Amendment No. 5 also beneficially owns more than 5% of the Issuer’s Common Stock through their indirect voting and dispositive power over the shares of Common Stock held by the Newtyn Funds. The Newtyn Reporting Persons periodically make filings on Form 4 and Schedule 13D to report their ownership of, and transactions in, the Common Stock and the interactions and agreements of the Newtyn Reporting Persons with the Board, members of management and the Reporting Persons substantially as described in the Reporting Persons’ Schedule 13D.

As the 13D Group is deemed to have acquired beneficial ownership of the aggregate amount of the Issuer’s Common Stock that the 13D Group members beneficially owns, the 13D Group is deemed to beneficially own 4,093,752 shares of Common Stock,1 representing 28.6% of the Issuer’s Common Stock outstanding for voting purposes. However, none of the Western Standard Parties have the ability to direct the acquisition or disposition or, except through the Cooperation Agreement, voting of the securities held by the Newtyn Parties, and none of the Newtyn Parties have the ability to direct the acquisition or disposition or, except through the Cooperation Agreement, voting of the securities held by the Western Standard Parties.

(a) & (b) The information relating to the beneficial ownership of Common Stock by each of the Reporting Persons set forth in Rows 7 through 13 of the cover pages hereto is incorporated by reference.

Western Standard Partner, L.P. is the beneficial owner 1,735,600 shares of Common Stock, representing approximately 12.1% of the Common Stock of the Issuer.

Western Standard and Eric D. Andersen are the beneficial owners of 2,220,058 shares of Common Stock, which consists of the shares of Common Stock held directly by the Funds, representing 15.5% of the Common Stock of the Issuer.

The Reporting Persons have sole power to vote, or direct the vote, and dispose of, or direct the disposition of, the reported shares of the Issuer’s Common Stock.

 

1 

Based on the 1,873,694 shares of Common Stock reported as held by Newtyn Management in its Form 13F for the quarterly period ended September 30, 2023 filed with the SEC on November 14, 2023.


The beneficial ownership percentage reported by each Reporting Person and the “group” herein was calculated based on 14,320,953 shares of Common Stock outstanding as of October 31, 2023, which number the Issuer reported in its Form 10-Q for the quarterly period ended September 30, 2023 filed with the SEC on November 2, 2023.

(c) Information with respect to all transactions in the securities which were effected during the past sixty days by each of the Reporting Persons is set forth on Schedule A annexed hereto and incorporated herein by reference.

(d) Not applicable.

(e) Not applicable.


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: December 13, 2023.

 

Western Standard, LLC
By:   /s/ Eric D. Andersen
  Eric D. Andersen, Managing Member

 

/s/ Eric D. Andersen
Eric D. Andersen

 

Western Standard Partners, L.P.
By: Western Standard, LLC, General Partner
By:   /s/ Eric D. Andersen
  Eric D. Andersen, Managing Member


SCHEDULE A

Transactions by the Reporting Persons in the securities of the Issuer during the preceding 60 days:

 

Fund Name

  

Transaction Date

  

Number of Shares

Bought/(Sold)

  

Price Per Share

(excluding

commission)

  

Type of

Transaction

Western Standard Partners, L.P.    11/8/2023    4,783    $12.1320    Open market
Western Standard Partners QP, L.P.    11/8/2023    9,040    $12.1320    Open market
Western Standard Partners, L.P.    11/9/2023    7,810    $12.1923    Open market
Western Standard Partners QP, L.P.    11/9/2023    2,165    $12.1923    Open market
Western Standard Partners, L.P.    11/10/2023    29,803    $12.3222    Open market
Western Standard Partners QP, L.P.    11/10/2023    8,259    $12.3222    Open market
Western Standard Partners, L.P.    11/13/2023    12,191    $12.3876    Open market
Western Standard Partners QP, L.P.    11/13/2023    3,379    $12.3876    Open market
Western Standard Partners, L.P.    11/14/2023    39,283    $12.5000    Open market
Western Standard Partners QP, L.P.    11/14/2023    10,887    $12.5000    Open market
Western Standard Partners, L.P.    11/17/2023    235    $12.5000    Open market
Western Standard Partners QP, L.P.    11/17/2023    65    $12.5000    Open market
Western Standard Partners, L.P.    12/07/2023    76,384    $12.8498    Open market
Western Standard Partners QP, L.P.    12/07/2023    24,666    $12.8498    Open market